Pyxis Oncology (PYXS) Short-term Investments (2021 - 2025)

Pyxis Oncology (PYXS) has 5 years of Short-term Investments data on file, last reported at $51.4 million in Q4 2025.

• On a quarterly basis, Short-term Investments fell 52.13% year-over-year to $51.4 million in Q4 2025; TTM through Dec 2025 was $51.4 million, a 52.13% decrease from a year earlier, with the FY2025 full-year figure at $51.4 million, down 52.13% from the prior year.
• Short-term Investments for Q4 2025 stood at $51.4 million, down from $67.3 million in the prior quarter.
• Over the last five years, Short-term Investments for PYXS reached as high as $132.8 million in Q3 2024 and fell as low as $1.5 million in Q4 2021.
• Historically, Short-term Investments has averaged $35.5 million across 5 years, with a median of $1.5 million in 2021.
• Across the five-year window, Short-term Investments surged 7933.42% in 2023 and slumped 52.13% in 2025, its largest moves.
• Year by year, Short-term Investments stood at $1.5 million in 2021, then changed by 0.0% to $1.5 million in 2022, then jumped by 7347.96% to $109.6 million in 2023, then fell by 1.98% to $107.5 million in 2024, then slumped by 52.13% to $51.4 million in 2025.
• Per Business Quant data, the three most recent Short-term Investments figures were $51.4 million in Q4 2025, $67.3 million in Q3 2025, and $1.5 million in Q2 2025.